Replies to post #736 on YM BioSciences Inc. (YMI)

[rarefind]

News Breaks
January 23, 2012
09:16 EDT YMI
theflyonthewall.com: YM Biosciences reported compelling data, says Roth Capital
Roth Capital believes that YM reported differentiated efficacy data, especially with regard to positive anemia responses, at ASH. The firm thinks that the company will land a major partnership n 1H12 and it reiterates a $6 target and Buy rating on the stock.

YMI should start a new move higher....rare